Area:
Neurobiology Biology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Deborah E. Bauer is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 2007 — 2008 |
Bauer, Deborah E |
F31Activity Code Description:
To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Excitatory Amino Acid Transporter Expression and Regulation in Schizophrenia @ University of Alabama At Birmingham
[unreadable] DESCRIPTION (provided by applicant): The excitatory amino acid transporters (EAATs) are a family of molecules responsible for synaptic glutamate reuptake. Expression and regulation of these transporters facilitates clearance of glutamate from the synapse and plays a pivotal role in long-term potentiation and synaptic plasticity. Compelling evidence has implicated cortical abnormalities of glutamate transmission in schizophrenia, but the precise role of the EAATs in schizophrenia remains unknown. It is hypothesized that expression and regulation of EAATs are altered in the prefrontal and anterior cingulate cortices in schizophrenia in a pattern consistent with increased glutamate reuptake. In postmortem tissue from patients with schizophrenia and control subjects, cell level gene expression will be measured using laser capture microscopy and quantitative PCR, post translational modification will be studied using enzymatic deglycoslation and Western blot analysis, and interaction between the transporters and a set of proteins that modulate transporter activity will be measured using co-immunoprecipitation. Schizophrenia affects 1% of the population worldwide and the cost to the U.S. in 2002 was estimated to be $62.7 billion. This research will lead to significant advances in our understanding of how glutamate reuptake may be altered in schizophrenia. Defining the specific abnormalities in glutamatergic neurotransmission may be used to target more effective diagnostic and treatment strategies. [unreadable] [unreadable] [unreadable]
|
0.954 |